Articles

Socioeconomic factors play a significant role in hospital readmission following outpatient parenteral antimicrobial therapy. Read More ›

Can costs associated with community-acquired bacterial pneumonia be reduced by implementing the site-of-care indicators regarding severity of illness recommended in the IDSA/ATS CAP guidelines? Read More ›

Eravacycline 1 mg/kg every 12 hours was demonstrated to be noninferior to ertapenem 1 g intravenously every 24 hours or meropenem in patients with complicated intra-abdominal infections. Read More ›

The use of oritavancin is a strategy to address the high economic burden secondary to prolonged hospitalization and high rates of recurrent infections associated with acute bacterial skin and skin structure infections. Read More ›

Omadacycline is a new intravenous/oral antibiotic for patients presenting in the emergency department with acute bacterial skin and soft tissue infections. Read More ›

In 2 parallel phase 3 trials, the diaminopyrimidine reductase inhibitor iclaprim showed noninferiority compared with vancomycin for the treatment of wound infections. Read More ›

Identifying social vulnerabilities that likely impact pediatric outpatient antimicrobial treatment after discharge could better enable treatment customization or prompt care coordination. Read More ›

Although community-acquired pneumonia (CAP) guidelines recommend transition to an oral beta-lactam regimen or fluoroquinolone (FQ) when patients are clinically stable, the collateral damage associated with FQ usage has led stewardship efforts to reduce initial FQ usage in CAP therapy. Read More ›

The US Food and Drug Administration has approved omadacycline for the treatment of adults with community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections. Read More ›

A dedicated infectious disease stewardship program can have immediate impact on patient safety, treatment of appropriate disease states, and the reduction of unnecessary readmission to the acute care hospital. Read More ›